REG - Prudential PLC - Repurchase to neutralise share issuances

PrudentialAnnouncement

Mon 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251215:nRSO4676La&default-theme=true

RNS Number : 4676L  Prudential PLC  15 December 2025

Prudential plc

 

Repurchase Programme to neutralise 2025 share issuances for scrip dividend

 

Prudential plc (the "Company") announces that it will commence a share
repurchase programme in respect of c. 2,200,000(( 1  (#_ftn1) )) ordinary
shares of 5 pence each ("Ordinary Shares"), in the issued share capital of the
Company (the "Programme").

 

The purpose of the Programme is to reduce the issued share capital of the
Company to offset dilution from shares issued under the scrip dividend
alternative in respect of the 2024 second interim dividend and the 2025 first
interim dividend of 16.29 and 7.71 US cents per Ordinary Share, respectively.
Based on the total number of Ordinary Shares in issue announced on 12 December
2025, the Programme approximates to 0.09% of the Company's issued share
capital. The Directors consider the Programme to be in the best interests of
the Company and of its shareholders generally. Given its small size, the
implementation of the Programme is expected to marginally enhance earnings per
share.

 

The Company intends to make further repurchases of its Ordinary Shares in
future including in order to offset issuances under the scrip dividend scheme
(if offered) and any expected dilution from the vesting of awards under
employee and agent share schemes.  The Company will make further
announcements in respect of any such repurchases in due course.

 

Detailed terms of the Programme

 

The Company has entered into an arrangement with Merrill Lynch International
("MLI") (acting as riskless principal) to conduct the repurchases in respect
of the Programme on its behalf.

 

The arrangement with MLI enables the purchase of Ordinary Shares for a period
from 15 December 2025, and will complete no later than 19 December 2025. The
aggregate maximum pecuniary amount allocated to the Programme is GBP 31
million (exclusive of associated fees, expenses and stamp duty) (equivalent to
HKD 322.2 million and USD 41.4 million, based on the closing exchange rate
between USD and GBP and USD and HKD as of 12 December 2025 HKT).

 

MLI may effect purchases of Ordinary Shares under the Programme on the London
Stock Exchange and/or other trading venues(( 2  (#_ftn2) )) for subsequent
purchase by the Company. Purchases by the Company will be treated as
on-exchange transactions subject to the Listing Rules of the London Stock
Exchange and as on-market purchases for the purpose of  the Hong Kong Code on
Share Buy-Backs. .The Company intends that any Ordinary Shares purchased will
be cancelled.

 

The Programme will run concurrently with the US$500 million third and final
tranche of the Company's US$2 billion share buyback programme, announced on 1
July 2025 and also being conducted by MLI (acting as riskless principal).

 

The Programme is in accordance with the Company's general authority to
purchase a maximum of 262,668,701 Ordinary Shares granted by shareholders at
the Company's 2025 Annual General Meeting. The Programme will be conducted
within the parameters prescribed by the Market Abuse Regulation 596/2014/EU
(as in force in the UK and as amended by the Market Abuse (Amendment) (EU
Exit) Regulations 2019), the Commission Delegated Regulation 2016/1052/EU (as
in force in the UK and as amended by the FCA's Technical Standards (Market
Abuse Regulation) (EU Exit) Instrument 2019) and in accordance with Chapter 9
of the UK Listing Rules, the Hong Kong Listing Rules and the Hong Kong Code on
Share Buy-backs. No purchase of Ordinary Shares will be conducted on the Hong
Kong Stock Exchange. No repurchases will be made in respect of the Company's
American Depositary Receipts.

 

The Company will make further announcements in due course following any
repurchase of shares. There is no guarantee that the Programme will be
implemented in full or that any shares will be repurchased by the Company.

Additional information

About Prudential plc

Prudential provides life and health insurance and asset management in Greater
China, ASEAN, India and Africa. Prudential's mission is to be the most trusted
partner and protector for this generation and generations to come, by
providing simple and accessible financial and health solutions. The business
has dual primary listings on the Stock Exchange of Hong Kong (HKEX: 2378) and
the London Stock Exchange (LSE: PRU). It also has a secondary listing on the
Singapore Stock Exchange (SGX: K6S) and a listing on the New York Stock
Exchange (NYSE: PUK) in the form of American Depositary Receipts. It is a
constituent of the Hang Seng Composite Index and is also included for trading
in the Shenzhen-Hong Kong Stock Connect programme and the Shanghai-Hong Kong
Stock Connect programme.

 

Prudential is not affiliated in any manner with Prudential Financial, Inc. a
company whose principal place of business is in the United States of America,
nor with The Prudential Assurance Company Limited, a subsidiary of M&G
plc, a company incorporated in the United Kingdom.

 

https://www.prudentialplc.com/ (https://www.prudentialplc.com/)

 

 

Contact

 

 Media                             Investors/Analysts
 Simon Kutner  +44 (0)7581 023260  Patrick Bowes       +852 9611 2981
 Sonia Tsang   +852 5580 7525      William Elderkin    +44 (0)20 3977 9215
                                   Ming Hau            +44 20 3977 9293
                                   Bosco Cheung        +852 2918 5499
                                   Tianjiao Yu         +852 2918 5487

 

(( 1  (#_ftnref1) )) Two million, one-hundred and ninety-seven-thousand, and
six-hundred sixty-nine (2,197,669) Ordinary Shares

(( 2  (#_ftnref2) )) Being any multilateral trading facility operated by
Turquoise Global Holdings Limited, CHI-X and BATS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCFLFIAFFLFLIE



            Copyright 2019 Regulatory News Service, all rights reserved